15 results on '"Arnold, Benjamin F"'
Search Results
2. Antenatal care attendance and risk of low birthweight in Burkina Faso: a cross-sectional study
- Author
-
Bountogo, Mamadou, Sié, Ali, Zakané, Alphonse, Compaoré, Guillaume, Ouédraogo, Thierry, Lebas, Elodie, Brogdon, Jessica, Nyatigo, Fanice, Arnold, Benjamin F., Lietman, Thomas M., and Oldenburg, Catherine E.
- Published
- 2021
- Full Text
- View/download PDF
3. Azithromycin for uncomplicated severe acute malnutrition: study protocol for a pilot randomized controlled trial
- Author
-
O’Brien, Kieran S., Sié, Ali, Dah, Clarisse, Ourohire, Millogo, Arzika, Ahmed M., Boudo, Valentin, Lebas, Elodie, Godwin, William W., Arnold, Benjamin F., and Oldenburg, Catherine E.
- Published
- 2021
- Full Text
- View/download PDF
4. Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial
- Author
-
Sié, Ali, Coulibaly, Boubacar, Dah, Clarisse, Bountogo, Mamadou, Ouattara, Mamadou, Compaoré, Guillaume, Brogdon, Jessica M., Godwin, William W., Lebas, Elodie, Doan, Thuy, Arnold, Benjamin F., Porco, Travis C., Lietman, Thomas M., and Oldenburg, Catherine E.
- Published
- 2021
- Full Text
- View/download PDF
5. Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
- Author
-
Amza, Abdou, Kadri, Boubacar, Nassirou, Beido, Arzika, Ahmed M., Austin, Ariana, Nyatigo, Fanice, Lebas, Elodie, Arnold, Benjamin F., Lietman, Thomas M., and Oldenburg, Catherine E.
- Published
- 2021
- Full Text
- View/download PDF
6. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
- Author
-
Oldenburg, Catherine E., Amza, Abdou, Cooley, Gretchen, Kadri, Boubacar, Nassirou, Beido, Arnold, Benjamin F., Rosenthal, Philip J., O’Brien, Kieran S., West, Sheila K., Bailey, Robin L., Porco, Travis C., Keenan, Jeremy D., Lietman, Thomas M., and Martin, Diana L.
- Published
- 2019
- Full Text
- View/download PDF
7. The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: a consensus statement
- Author
-
Cumming, Oliver, Arnold, Benjamin F., Ban, Radu, Clasen, Thomas, Esteves Mills, Joanna, Freeman, Matthew C., Gordon, Bruce, Guiteras, Raymond, Howard, Guy, Hunter, Paul R., Johnston, Richard B., Pickering, Amy J., Prendergast, Andrew J., Prüss-Ustün, Annette, Rosenboom, Jan Willem, Spears, Dean, Sundberg, Shelly, Wolf, Jennyfer, Null, Clair, Luby, Stephen P., Humphrey, Jean H., and Colford, Jr., John M.
- Published
- 2019
- Full Text
- View/download PDF
8. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
- Author
-
O'Brien, Kieran S., Arzika, Ahmed M., Amza, Abdou, Maliki, Ramatou, Ousmane, Sani, Kadri, Boubacar, Nassirou, Beido, Mankara, Alio Karamba, Harouna, Abdoul Naser, Colby, Emily, Lebas, Elodie, Liu, Zijun, Le, Victoria, Nguyen, William, Keenan, Jeremy D., Oldenburg, Catherine E., Porco, Travis C., Doan, Thuy, Arnold, Benjamin F., and Lietman, Thomas M.
- Subjects
AZITHROMYCIN ,DRUG resistance in microorganisms ,MACROLIDE antibiotics ,MORTALITY ,ANTIBIOTICS ,RESEARCH ,CLINICAL trials ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RANDOMIZED controlled trials ,RESEARCH funding - Abstract
Background: Biannual distribution of azithromycin to children 1-59 months old reduced mortality by 14% in a cluster-randomized trial. The World Health Organization has proposed targeting this intervention to the subgroup of children 1-11 months old to reduce selection for antimicrobial resistance. Here, we describe a trial designed to determine the impact of age-based targeting of biannual azithromycin on mortality and antimicrobial resistance.Methods: AVENIR is a cluster-randomized, placebo-controlled, double-masked, response-adaptive large simple trial in Niger. During the 2.5-year study period, 3350 communities are targeted for enrollment. In the first year, communities in the Dosso region will be randomized 1:1:1 to 1) azithromycin 1-11: biannual azithromycin to children 1-11 months old with placebo to children 12-59 months old, 2) azithromycin 1-59: biannual azithromycin to children 1-59 months old, or 3) placebo: biannual placebo to children 1-59 months old. Regions enrolled after the first year will be randomized with an updated allocation based on the probability of mortality in children 1-59 months in each arm during the preceding study period. A biannual door-to-door census will be conducted to enumerate the population, distribute azithromycin and placebo, and monitor vital status. Primary mortality outcomes are defined as all-cause mortality rate (deaths per 1000 person-years) after 2.5 years from the first enrollment in 1) children 1-59 months old comparing the azithromycin 1-59 and placebo arms, 2) children 1-11 months old comparing the azithromycin 1-11 and placebo arm, and 3) children 12-59 months in the azithromycin 1-11 and azithromycin 1-59 arms. In the Dosso region, 50 communities from each arm will be followed to monitor antimicrobial resistance. Primary resistance outcomes will be assessed after 2 years of distributions and include 1) prevalence of genetic determinants of macrolide resistance in nasopharyngeal samples from children 1-59 months old, and 2) load of genetic determinants of macrolide resistance in rectal samples from children 1-59 months old.Discussion: As high-mortality settings consider this intervention, the results of this trial will provide evidence to support programmatic and policy decision-making on age-based strategies for azithromycin distribution to promote child survival.Trial Registration: This trial was registered on January 13, 2020 (clinicaltrials.gov: NCT04224987 ). [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
9. Azithromycin for uncomplicated severe acute malnutrition: study protocol for a pilot randomized controlled trial.
- Author
-
O'Brien, Kieran S., Sié, Ali, Dah, Clarisse, Ourohire, Millogo, Arzika, Ahmed M., Boudo, Valentin, Lebas, Elodie, Godwin, William W., Arnold, Benjamin F., and Oldenburg, Catherine E.
- Subjects
AZITHROMYCIN ,MALNUTRITION ,TREATMENT effectiveness ,AMOXICILLIN ,WEIGHT gain ,RANDOMIZED controlled trials - Abstract
Background: Given the high risk of infectious mortality among children with severe acute malnutrition (SAM), the World Health Organization recommends routine administration of a broad-spectrum antibiotic like amoxicillin as part of the management of uncomplicated SAM. However, evidence for the efficacy of amoxicillin to improve nutritional recovery or reduce mortality has been mixed. With a long half-life and evidence of efficacy to reduce mortality in high-risk populations, azithromycin is a potential alternative to amoxicillin in the management of SAM. In this pilot study, we aim to compare the efficacy of azithromycin to amoxicillin to improve nutritional outcomes in children with uncomplicated SAM. Methods: This pilot randomized controlled trial will enroll 300 children with uncomplicated SAM from 6 Centre de Santé et de Promotion Sociale in the Boromo health district in Burkina Faso. Eligible children are randomized to receive a single directly observed dose of oral azithromycin or a 7-day course of oral amoxicillin in addition to the standard package of care for uncomplicated SAM. Enrolled children are followed weekly until nutritional recovery, and all children return for a final study visit at 8 weeks after enrollment. Anthropometric indicators, vital status, and clinical outcomes are monitored at each visit and compared by arm. Primary feasibility outcomes include enrollment potential, refusals, loss to follow-up, and completeness of data collection. The primary clinical outcome is weight gain (g/kg/day) over the 8-week study period. Discussion: This pilot trial will establish the feasibility of conducting a full-scale randomized controlled trial to evaluate alternative antibiotics in this setting and provide preliminary evidence for the efficacy of azithromycin compared to amoxicillin to improve outcomes for children with SAM. Trial registration: This trial was first registered on clinicaltrials.gov on 26 June 2018 (NCT03568643). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Distance to primary care facilities and healthcare utilization for preschool children in rural northwestern Burkina Faso: results from a surveillance cohort.
- Author
-
Oldenburg, Catherine E., Sié, Ali, Ouattara, Mamadou, Bountogo, Mamadou, Boudo, Valentin, Kouanda, Idrissa, Lebas, Elodie, Brogdon, Jessica M., Lin, Ying, Nyatigo, Fanice, Arnold, Benjamin F., Lietman, Thomas M., and Étude CHAT Study Group
- Subjects
HEALTH facilities ,PRESCHOOL children ,RURAL children ,PRIMARY care ,DIAGNOSIS - Abstract
Background: Delays in care-seeking for childhood illness may lead to more severe outcomes. We evaluated whether community distance from a primary healthcare facility was associated with decreased healthcare utilization in a rural district of northwestern Burkina Faso.Methods: We conducted passive surveillance of all government-run primary healthcare facilities in Nouna District, Burkina Faso from March 1 through May 31, 2020. All healthcare visits for children under 5 years of age were recorded on a standardized form for sick children. We recorded the age, sex, and community of residence of the child as well as any diagnoses and treatments administered. We calculated healthcare utilization per 100 child-months by linking the aggregate number of visits at the community level to the community's population of children under 5 months per a census that was conducted from August 2019 through February 2020. We calculated the distance between each community and its corresponding healthcare facility and assessed the relationship between distance and the rate of healthcare utilization.Results: In 226 study communities, 12,676 primary healthcare visits were recorded over the three-month period. The median distance between the community and primary healthcare facility was 5.0 km (IQR 2.6 to 6.9 km), and median number of healthcare visits per 100 child-months at the community level was 6.7 (IQR 3.7 to 12.3). The rate of primary healthcare visits declined with increasing distance from clinic (Spearman's rho - 0.42, 95% CI - 0.54 to - 0.31, P < 0.0001). This relationship was similar for cause-specific clinic visits (including pneumonia, malaria, and diarrhea) and for antibiotic prescriptions.Conclusions: We documented a distance decay effect between community distance from a primary healthcare facility and the rate of healthcare visits for children under 5. Decreasing distance-related barriers, for example by increasing the number of facilities or targeting outreach to more distant communities, may improve healthcare utilization for young children in similar settings. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
- Author
-
Acharya, Nisha R., Ebert, Caleb D., Kelly, Nicole K., Porco, Travis C., Ramanan, Athimalaipet V., Arnold, Benjamin F., the ADJUST Research Group, Doan, Thuy, Gonzales, John A., von Scheven, Emily, Angeles-Han, Shelia T., Miraldi Utz, Virginia, Vitale, Albert T., Hersh, Aimee O., Overbury, Rebecca S., Stahl, Erin D., Cooper, Ashley M., Lerman, Melissa A., Davidson, Stefanie L., and Thorne, Jennifer E.
- Subjects
ADALIMUMAB ,RANDOMIZED controlled trials ,UVEITIS ,JUVENILE idiopathic arthritis ,EYE inflammation ,INFECTIOUS arthritis ,VISION disorders - Abstract
Background: Juvenile idiopathic arthritis (JIA)-associated uveitis is a chronic paediatric ocular inflammatory condition that can result in visual impairment. Adalimumab, a tumour necrosis factor (TNF)-alpha inhibitor, effectively controls joint and eye inflammation; however, its long-term use may increase the risk of adverse health outcomes and place an undue financial burden on the patient and healthcare system given its high cost. There is great interest for patients to stop adalimumab following remission due to these reasons but there is a lack of information on the ability to maintain control after discontinuing adalimumab.Methods: The Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Trial (ADJUST) is a multicentred, international trial that will randomise 118 participants aged 2 years and older with controlled JIA-associated uveitis to either continue adalimumab or discontinue adalimumab and receive a placebo. The trial will compare the time to uveitis recurrence between the two groups over 12 months. All participants will receive the standard weight-based dose of adalimumab or placebo: 20 mg biweekly (if < 30 kg) or 40 mg biweekly (if ≥ 30 kg).Discussion: This is the first randomised controlled trial to assess the efficacy of discontinuing adalimumab after demonstrating control of JIA-associated uveitis for at least 12 months. The results of ADJUST will provide information on clinical outcomes to guide clinicians in their decision-making regarding discontinuation of adalimumab.Trial Registration: ClinicalTrials.gov NCT03816397. Registered on 25 January 2019. EudraCT 2019-000412-29. Registered on 17 January 2019. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
12. The risk of misclassifying subjects within principal component based asset index.
- Author
-
Yushuf Sharker, M. A., Nasser, Mohammed, Abedin, Jaynal, Arnold, Benjamin F., and Luby, Stephen P.
- Subjects
ANALYSIS of variance ,ASSETS (Accounting) ,CLASSIFICATION ,COMPUTER simulation ,FACTOR analysis ,HEALTH status indicators ,RESEARCH methodology ,PATIENTS ,POVERTY ,PROBABILITY theory ,CONTENT mining ,RESEARCH methodology evaluation ,DESCRIPTIVE statistics - Abstract
The asset index is often used as a measure of socioeconomic status in empirical research as an explanatory variable or to control confounding. Principal component analysis (PCA) is frequently used to create the asset index. We conducted a simulation study to explore how accurately the principal component based asset index reflects the study subjects' actual poverty level, when the actual poverty level is generated by a simple factor analytic model. In the simulation study using the PC-based asset index, only 1% to 4% of subjects preserved their real position in a quintile scale of assets; between 44% to 82% of subjects were misclassified into the wrong asset quintile. If the PCbased asset index explained less than 30% of the total variance in the component variables, then we consistently observed more than 50% misclassification across quintiles of the index. The frequency of misclassification suggests that the PC-based asset index may not provide a valid measure of poverty level and should be used cautiously as a measure of socioeconomic status. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Simulation methods to estimate design power: an overview for applied research.
- Author
-
Arnold, Benjamin F., Hogan, Daniel R., Colford, Jr., John M., and Hubbard, Alan E.
- Subjects
- *
STATISTICAL sampling , *SIMULATION methods & models , *SAMPLE size (Statistics) , *MEDICAL research , *EPIDEMIOLOGY - Abstract
Background: Estimating the required sample size and statistical power for a study is an integral part of study design. For standard designs, power equations provide an efficient solution to the problem, but they are unavailable for many complex study designs that arise in practice. For such complex study designs, computer simulation is a useful alternative for estimating study power. Although this approach is well known among statisticians, in our experience many epidemiologists and social scientists are unfamiliar with the technique. This article aims to address this knowledge gap. Methods: We review an approach to estimate study power for individual- or cluster-randomized designs using computer simulation. This flexible approach arises naturally from the model used to derive conventional power equations, but extends those methods to accommodate arbitrarily complex designs. The method is universally applicable to a broad range of designs and outcomes, and we present the material in a way that is approachable for quantitative, applied researchers. We illustrate the method using two examples (one simple, one complex) based on sanitation and nutritional interventions to improve child growth. Results: We first show how simulation reproduces conventional power estimates for simple randomized designs over a broad range of sample scenarios to familiarize the reader with the approach. We then demonstrate how to extend the simulation approach to more complex designs. Finally, we discuss extensions to the examples in the article, and provide computer code to efficiently run the example simulations in both R and Stata. Conclusions: Simulation methods offer a flexible option to estimate statistical power for standard and nontraditional study designs and parameters of interest. The approach we have described is universally applicable for evaluating study designs used in epidemiologic and social science research. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
14. Factors associated with compliance among users of solar water disinfection in rural Bolivia.
- Author
-
Christen, Andri, Pacheco, Gonzalo Duran, Hattendorf, Jan, Arnold, Benjamin F., Cevallos, Myriam, Indergand, Stefan, Colford, John M., and Mäusezahl, Daniel
- Subjects
DRINKING water ,DIARRHEA ,DISINFECTION & disinfectants ,CHILD mortality - Abstract
Background: Diarrhoea is the second leading cause of childhood mortality, with an estimated 1.3 million deaths per year. Promotion of Solar Water Disinfection (SODIS) has been suggested as a strategy for reducing the global burden of diarrhoea by improving the microbiological quality of drinking water. Despite increasing support for the large-scale dissemination of SODIS, there are few reports describing the effectiveness of its implementation. It is, therefore, important to identify and understand the mechanisms that lead to adoption and regular use of SODIS. Methods: We investigated the behaviours associated with SODIS adoption among households assigned to receive SODIS promotion during a cluster-randomized trial in rural Bolivia. Distinct groups of SODIS-users were identified on the basis of six compliance indicators using principal components and cluster analysis. The probability of adopting SODIS as a function of campaign exposure and household characteristics was evaluated using ordinal logistic regression models. Results: Standardised, community-level SODIS-implementation in a rural Bolivian setting was associated with a median SODIS use of 32% (IQR: 17-50). Households that were more likely to use SODIS were those that participated more frequently in SODIS promotional events (OR = 1.07, 95%CI: 1.01-1.13), included women (OR = 1.18, 95%CI: 1.07-1.30), owned latrines (OR = 3.38, 95%CI: 1.07-10.70), and had severely wasted children living in the home (OR = 2.17, 95%CI: 1.34-3.49). Conclusions: Most of the observed household characteristics showed limited potential to predict compliance with a comprehensive, year-long SODIS-promotion campaign; this finding reflects the complexity of behaviour change in the context of household water treatment. However, our findings also suggest that the motivation to adopt new water treatment habits and to acquire new knowledge about drinking water treatment is associated with prior engagements in sanitary hygiene and with the experience of contemporary family health concerns. Household-level factors like the ownership of a latrine, a large proportion of females and the presence of a malnourished child living in a home are easily assessable indicators that SODIS-programme managers could use to identify early adopters in SODIS promotion campaigns. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
15. The risk of misclassifying subjects within principal component based asset index.
- Author
-
Sharker MY, Nasser M, Abedin J, Arnold BF, and Luby SP
- Abstract
The asset index is often used as a measure of socioeconomic status in empirical research as an explanatory variable or to control confounding. Principal component analysis (PCA) is frequently used to create the asset index. We conducted a simulation study to explore how accurately the principal component based asset index reflects the study subjects' actual poverty level, when the actual poverty level is generated by a simple factor analytic model. In the simulation study using the PC-based asset index, only 1% to 4% of subjects preserved their real position in a quintile scale of assets; between 44% to 82% of subjects were misclassified into the wrong asset quintile. If the PC-based asset index explained less than 30% of the total variance in the component variables, then we consistently observed more than 50% misclassification across quintiles of the index. The frequency of misclassification suggests that the PC-based asset index may not provide a valid measure of poverty level and should be used cautiously as a measure of socioeconomic status.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.